Sep 16, 2025 16:29
ANIX - Anixa Biosciences, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
4.33 0.16 (3.7%) | --- | --- | --- | 0.0 (0.0%) | 0.16 (3.7%) | --- | 0.0 (0.0%) |
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.07
- Diluted EPS:
- -0.07
- Basic P/E:
- -64.1429
- Diluted P/E:
- -64.1429
- RSI(14) 1m:
- 64.73
- VWAP:
- 4.48
- RVol:
- 0.5852
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 4.38 -0.06 (-1.35%) | Oct 15 10:04 |
60m | Price increase 60m | 4.47 +0.22 (+5.19%) | Oct 15 09:46 |
Related News
Oct 31, 2024 12:15
Jul 23, 2024 11:45
Jul 15, 2024 16:17
Nov 17, 2023 14:06
Nov 17, 2023 14:00
Nov 15, 2023 13:00
Nov 14, 2023 15:29
Nov 10, 2023 12:19
Nov 10, 2023 11:30